Urology Times Newsletter

To view this email as a web page, click here.

MALPRACTICE CONSULT

Resident, attending sued over BPH procedure

“This case helps to highlight important considerations around the level of involvement and supervision for trainees,” writes Brianne Goodwin, JD, RN.

Read her column

Undetected kidney tumor leads to lawsuit

"The plaintiff claimed the decedent’s cancer should have been diagnosed by the original urologist at least 3 years before the actual diagnosis, and claimed that timely diagnosis and treatment would have prevented the spread of the cancer," writes Acacia Brush Perko, Esq.

Learn more

SURVEY

Is DRE still a relevant tool in the management of prostate cancer?

Dr. Igor Sorokin describes his medical treatment goal for four patients presenting with clinical hypercalciuria: one with Medullary Sponge Disease, one taking Topamax, one with a solitary kidney and one with hyperparathyroidism. He points out what abnormalities to look for on the 24-hour urine test and interprets the lab results of each patient’s sample. He also discusses both dietary adjustments and pharmacological management techniques to reduce stone recurrence risk for each patient.

Learn more

MORE FROM UROLOGY TIMES

Who’s to blame for man’s loss of kidney function?

Teleurology: The time has arrived

JOB OPPORTUNITIES

NY-WNY Urology Associates

VT-University of Vermont

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.